Brief: Kyowa Kirin Co Says Tenapanor For Hyperphosphatemia Approved In Japan
25/09/2023 09:20
Sept 25 (Reuters) - Kyowa Kirin Co Ltd 4151.T :
* TENAPANOR FOR HYPERPHOSPHATEMIA APPROVED IN JAPAN
Source text for Eikon: ID:nGNXnnBDN
Further company coverage: 4151.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ardelyx
See all newsArdelyx, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ardelyx says Q2 product revenue at record high but IBSRELA revenue below expectations
Brief: Ardelyx Q2 Product Sales USD 118.129 Million
Ardelyx Q1 product revenue rises 38% on IBSRELA growth
Brief: Ardelyx Q1 Product Sales USD 93.373 Million